Stock Code3839( Incorporated in Bermuda with members’ limited liability於百慕達註冊成立之成員有限責任公司 )股份代號 : 目錄CONTENTS Chairman’s Statement董事長報告書Financial Highlights財務概要Management Discussion and Analysis管理層討論及分析Corporate Governance Report企業管治報告Biographical Details of Directors董事履歷詳情Report of the Directors董事報告書Independent Auditor’s Report獨立核數師報告Consolidated Statement of Comprehensive Income綜合全面收益表Consolidated Statement of Financial Position綜合財務狀況表Consolidated Statement of Changes in Equity綜合權益變動表Consolidated Statement of Cash Flows綜合現金流量表Notes to the Financial Statements財務報表附註Corporate Information公司資料24593641596668707274151 Chairman’s Statement董 事 長 報 告 書 In 2024, although the global economy’s recovery path was still fullof challenges, technological innovations and the flourishing digitaleconomy presented new opportunities to enterprises. In such amacroeconomic environment with both opportunities and challenges,Chia Tai Enterprises International Limited and its subsidiaries (the“Group”) were able to proactively embrace changes and adapt to newsituations. Drawing on keen market acumen, courage to take decisiveactions and tenacious fighting spirit, the Group achieved impressivebusiness growth in 2024. On the biochemical business front, with farming operations scalingup and animal health business going for high-quality development,scientific innovations and technical services have become crucialgrowthdrivers of the industry.Continuing with its strategictransformation, the Group pushed forward to diversify its animalhealth product business. In order to ensure relevant businesseshave strong commercial potential in future development, we havebeen stepping up research and development investments, focusingon research and applications of emerging technologies, as wellas employing artificial intelligence and related tools to drive keytechnology upgrades. At the same time, the Group actively exploredmarket channels and strengthened in-depth cooperation with leadingcompanies in the industry, expanding its market share as a result. Inaddition, the Group actively took part in trade exhibitions at homeand abroad to showcase its innovative products and technologicaladvantages. These activities have helped to enhance our brandinfluence in the market place. Duringthe year,the Group,as always,actively honoured itssocial responsibility by participating in various social welfare andcharitable events, such as sponsoring medical supplies and promotinggreening. In terms of human resources, we continued to bring intalent of high calibre and wholeheartedly pressed on with researchand development, production, as well as sales undertakings. Also,by further improving our manpower structure and staff quality, asolid foundation has been laid for the Group to achieve sustainabledevelopment via enhancement of efficiency and strengthening ofoverall competitiveness. Chairman’s Statement董 事 長 報 告 書 As the large-size excavator market was affected by the country’sslowing down in infrastructure investment and the mining sector’sholdingback in spending,the performance of our Caterpillardealership business was less than satisfactory. On the other hand,while facing a complex market environment, our automotive partsbusiness achieved stable overall performance in 2024. This result wasachieved by stabilizing its traditional carburetor business and activelypursuing the new energy vehicle subcomponent business. Looking forward, we will continue to uphold our “Three BenefitsPrinciple” – benefiting the countries in which we operate, benefitingthe people whose community we share and benefiting the enterprisesfor which we are responsible. We would abide by laws and regulations;wewould step up efforts in technological innovation,marketexpansion and talent grooming; and we would work hard to meet therequirements of high-quality development. These efforts would ensurewe are ready to realise our business aspirations for 2025. Last but not least, my heartfelt thanks go to all employees for theirhard work and contribution in the past year and also to shareholdersfor their trust and support. Soopakij ChearavanontChairman Hong Kong, 24 February 2025 Financial Highlights財 務 概 要 Management Discussion and Analysis管 理 層 討 論 及 分 析 GROUP RESULTS 集團業績 ECI Metro Investment Co., Ltd.ECI Metro The Group has two lines of business: biochemical business andindustrial business. The biochemical business focuses on animalhealth products and chlortetracycline (“CTC”), and is carried onby Group subsidiaries. This business segment accounts for all of theGroup’s consolidated revenue. The industrial business comprises theGroup’s interests in its joint venture ECI Metro Investment Co.,Ltd. (together with its subsidiaries, “ECI Metro”) and its associateZhanjiang Deni Vehicle Parts Co., Ltd. (together with its subsidiaries,“Zhanjiang Deni”). The results of the Group’s industrial business areincorporated in the consolidated statement of comprehensive incomeas share of profits and los